|
|
|
|
Warfarin-treated patients at higher risk of ICH following tPA for stroke
_ Warfarin-treated patients at higher risk of ICH following tPA for stroke.
|
|
|
Warfarin-Treated Patients at Higher Risk for ICH Following tPA for Stroke
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.To find out how to adjust your browser settings to accept cookies, please click here. Medscape uses cookies to customize the site based on the information...
|
|
|
Warfarin-Treated Patients at Higher Risk for ICH Following tPA for Stroke
_ Warfarin-Treated Patients at Higher Risk for ICH Following tPA for Stroke.
|
|
|
After Stroke Treatment Anticoagulant Users More Vulnerable to Hemorrhage
A new study has found that Warfarin users appear more likely to develop brain After Stroke Treatment Anticoagulant Users More Vulnerable to Hemorrhage.
|
|
|
VTE Preventive Therapy Reduces Costs, But Adherence Is Often Lacking
Drug therapy to prevent venous thromboembolism offers significant health care cost benefits.However, only a small fraction of patients are receiving appropriate prophylactic treatment, study results showed. SAN DIEGO-Less than half of patients who were at...
|
|
|
Bleeding Alert Sounded for Stroke Drugs
MONDAY, March 8 (HealthDay News) -- People treated with the clot-dissolving drug tPA for a stroke caused by a blocked brain artery are significantly more likely to have excess bleeding if they have been taking the anti-clotting drug Coumadin, even though a test...
|
|
|
Stroke Patients Already on Warfarin at Risk of Intracerebral Bleeding After tPA
Patients treated with intravenous tissue plasminogen activator (tPA) for acute ischemic stroke may be at higher risk of intracerebral hemorrhage if they are already taking warfarin therapy, even if their clotting function is within normal parameters,...
|
|
|
Warfarin Users More Likely to Develop Brain Haemorrhage Following Stroke Treatment
-- Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain haemorrhage following treatment with intravenous tissue plasminogen activator (tPA), even if their blood clotting function appears normal, according...
|
|
|
Alarm raised over INR threshold in stroke thrombolysis
MedWire News: Stroke patients undergoing thrombolysis are at increased risk for symptomatic intracerebral hemorrhage (ICH) if they are taking warfarin, even if their international normalized ratio (INR) is within recommended limits, research suggests.
|
|
|
Warfarin Users Appear More Likely To Develop Brain Bleeding Following Stroke Treatment
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a...
|
|
|
Warfarin Users Appear More Likely To Develop Brain Bleeding Following Stroke Treatment
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a...
|
|
|
Warfarin Users Appear More Likely to Develop Brain Bleeding Following Stroke Treatment
Newswise Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according...
|
|
|
Warfarin users appear more likely to develop brain bleeding following stroke treatment
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a...
|
|
|
Patients taking warfarin who develop acute stroke more likely to experience brain hemorrhage
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, according to a...
|
|
|
The Long-Term Consequences Of Intravenous Nutrition On Children's Health
Children with serious intestinal problems have to be fed intravenously.Systems exist that enable intravenous feeding to be carried out at home. Mr Inaki Irastorza, paediatrician at the Cruces hospital in Bilbao, spent some 15 years analysing how serious...
|
|
|
Domiciliary parenteral nutrition helps children with serious intestinal problems live more normally
Children with serious intestinal problems have to be fed intravenously.There moreover, exist systems that enable intravenous feeding to be carried out at home. Mr I-aki Irastorza, paediatrician at the Cruces hospital in Bilbao, spent some 15 years...
|
|
|
ACC Highlights 30 Late-Breaking Trials
The most recent data from 30 late-breaking clinical trials is being highlighted during the American College of Cardiology (ACC) 2010 scientific sessions, March 14-16 in Atlanta.New this year are the Trialist Is In round-table sessions, held 3:30-4:30 p.m.
|
|
|
Bleeding Alert Sounded for Stroke Drugs
MONDAY, March 8 (HealthDay News) -- People treated with the clot-dissolving drug tPA for a stroke caused by a blocked brain artery are significantly more likely to have excess bleeding if they have been taking the anti-clotting drug Coumadin, even though a test...
|
|
|
Personalized Medicine on the Spot
Different people can react to drugs in different ways, and in some cases the response can be predicted from their genes.For example, the drug warfarin, often used to prevent blood clots, can cause dangerous bleeding in some patients. Researchers have...
|
|
|
Hi The article by Prof Byard contains too many incorrect statements about the dangers of herbal...'
Many complementary medicines contained dangerous levels of arsenic, mercury and lead, and could be potentially deadly, a leading forensic pathologist has warned.Professor Roger Byard from the University of Adelaide has warned against the 'false perception'...
|
|
|
Personalized medicine in warfarin therapy
Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose.Warfarin is an anti-coagulant that is commonly used to prevent blood...
|
|
|
Long-term Effect of Chronic Oral Anticoagulation with Warfarin after Acute Myocardial Infarction
Haq SA et al.Antiplatelet therapy is the principal component of the antithrombotic regimen after acute myocardial infarction. It remains unclear whether additional chronic oral anticoagulation (OAC) improves outcomes... Long-term Effect of Chronic Oral...
|
|
|
Fecal Occult Blood Test in Patients on Low-Dose Aspirin, Warfarin, Clopidogrel, or Non-steroidal Anti-inflammatory Drugs
Sawhney MS et al.Fecal Occult Blood Test in Patients on Low-Dose Aspirin, Warfarin, Clopidogrel, or Non-steroidal Anti-inflammatory Drugs.
|
|
|
Preventing Thromboembolism After Knee Surgery: Apixaban More Effective Than Enoxaparin
An article published in today reports that apixaban is a more convenient and effective anticoagulant than enoxaparin.It is better at preventing venous thromboembolism after knee replacement surgery. Also, apixaban does not increase the risk of bleeding.
|
|
|
Apixaban more effective than enoxaparin in preventing thromboembolism
These favourable results might help surgeons to resolve their clinical dilemma when considering anticoagulant prophylaxis for total knee replacement Michael Rud Lassen et al.An article published in The Lancet reports that apixaban is a more convenient and...
|
